ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 114 filers reported holding ANAPTYSBIO INC in Q1 2023. The put-call ratio across all filers is 0.91 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,713,859 | -8.1% | 206,785 | +4.1% | 0.02% | -4.3% |
| Q2 2023 | $4,041,985 | +16.5% | 198,721 | +24.6% | 0.02% | +9.5% |
| Q1 2023 | $3,470,872 | +1026.9% | 159,507 | +949.7% | 0.02% | +950.0% |
| Q2 2022 | $308,000 | -88.8% | 15,196 | -86.4% | 0.00% | -89.5% |
| Q1 2022 | $2,756,000 | -11.2% | 111,407 | +24.7% | 0.02% | -9.5% |
| Q4 2021 | $3,104,000 | +29.4% | 89,317 | +1.0% | 0.02% | +31.2% |
| Q3 2021 | $2,398,000 | +3.7% | 88,428 | -0.8% | 0.02% | 0.0% |
| Q2 2021 | $2,312,000 | +13.9% | 89,166 | -5.3% | 0.02% | 0.0% |
| Q1 2021 | $2,030,000 | +32.2% | 94,205 | +32.0% | 0.02% | +23.1% |
| Q4 2020 | $1,535,000 | +46.9% | 71,378 | +0.7% | 0.01% | +18.2% |
| Q3 2020 | $1,045,000 | -26.5% | 70,851 | +11.4% | 0.01% | -26.7% |
| Q2 2020 | $1,421,000 | +190.6% | 63,591 | +83.9% | 0.02% | +150.0% |
| Q1 2020 | $489,000 | – | 34,585 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 1,950,609 | $35,032,938 | 4.94% |
| EcoR1 Capital, LLC | 7,521,024 | $135,077,591 | 4.56% |
| Saturn V Capital Management LP | 577,101 | $10,364,734 | 4.34% |
| GREAT POINT PARTNERS LLC | 894,333 | $16,062,221 | 2.93% |
| 5AM Venture Management, LLC | 357,733 | $6,424,885 | 1.85% |
| First Light Asset Management, LLC | 790,806 | $14,202,876 | 1.35% |
| Boxer Capital, LLC | 1,300,000 | $23,348,000 | 1.24% |
| Frazier Life Sciences Management, L.P. | 899,700 | $16,158,612 | 1.07% |
| Deep Track Capital, LP | 1,345,813 | $24,170,801 | 0.93% |
| Palo Alto Investors LP | 431,224 | $7,744,783 | 0.73% |